Sabra Ptb Ratio vs Dividend Yield Analysis

SBRA Stock  USD 18.91  0.07  0.37%   
Sabra Healthcare financial indicator trend analysis is much more than just breaking down Sabra Healthcare REIT prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sabra Healthcare REIT is a good investment. Please check the relationship between Sabra Healthcare Ptb Ratio and its Dividend Yield accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Ptb Ratio vs Dividend Yield

Ptb Ratio vs Dividend Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sabra Healthcare REIT Ptb Ratio account and Dividend Yield. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Sabra Healthcare's Ptb Ratio and Dividend Yield is -0.59. Overlapping area represents the amount of variation of Ptb Ratio that can explain the historical movement of Dividend Yield in the same time period over historical financial statements of Sabra Healthcare REIT, assuming nothing else is changed. The correlation between historical values of Sabra Healthcare's Ptb Ratio and Dividend Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ptb Ratio of Sabra Healthcare REIT are associated (or correlated) with its Dividend Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Dividend Yield has no effect on the direction of Ptb Ratio i.e., Sabra Healthcare's Ptb Ratio and Dividend Yield go up and down completely randomly.

Correlation Coefficient

-0.59
Relationship DirectionNegative 
Relationship StrengthVery Weak

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Dividend Yield

Dividend Yield is Sabra Healthcare REIT dividend as a percentage of Sabra Healthcare stock price. Sabra Healthcare REIT dividend yield is a measure of Sabra Healthcare stock productivity, which can be interpreted as interest rate earned on an Sabra Healthcare investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.
Most indicators from Sabra Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sabra Healthcare REIT current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
At present, Sabra Healthcare's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 29.83, whereas Selling General Administrative is forecasted to decline to about 29.5 M.
 2021 2022 2023 2024 (projected)
Gross Profit428.3M462.2M269.2M325.5M
Total Revenue569.5M624.8M647.5M404.3M

Sabra Healthcare fundamental ratios Correlations

0.95-0.670.650.990.440.480.98-0.560.910.440.790.80.410.450.440.860.870.430.980.930.990.390.670.94-0.61
0.95-0.740.630.950.390.610.91-0.550.940.410.780.790.560.560.410.820.850.530.910.930.920.330.70.91-0.62
-0.67-0.74-0.02-0.67-0.51-0.05-0.62-0.07-0.63-0.43-0.85-0.86-0.10.04-0.43-0.32-0.42-0.3-0.67-0.59-0.66-0.14-0.62-0.510.03
0.650.63-0.020.670.040.760.63-0.940.630.070.110.120.810.840.070.940.770.280.590.740.610.370.280.77-0.9
0.990.95-0.670.670.380.540.96-0.590.940.380.790.80.460.490.380.880.90.450.950.970.960.380.640.96-0.65
0.440.39-0.510.040.38-0.170.490.070.260.360.450.46-0.08-0.180.360.190.16-0.090.520.240.50.140.390.230.06
0.480.61-0.050.760.54-0.170.43-0.840.69-0.090.170.170.840.98-0.090.730.760.60.370.70.40.260.260.7-0.87
0.980.91-0.620.630.960.490.43-0.550.860.390.760.770.340.40.390.830.850.410.990.880.990.420.660.91-0.6
-0.56-0.55-0.07-0.94-0.590.07-0.84-0.55-0.610.09-0.05-0.07-0.75-0.890.09-0.88-0.79-0.48-0.48-0.7-0.51-0.38-0.28-0.740.98
0.910.94-0.630.630.940.260.690.86-0.610.280.80.80.520.630.280.840.90.630.850.950.850.280.650.94-0.71
0.440.41-0.430.070.380.36-0.090.390.090.280.430.43-0.07-0.081.00.190.040.120.510.250.5-0.020.680.250.07
0.790.78-0.850.110.790.450.170.76-0.050.80.430.99-0.010.060.430.430.590.450.790.70.780.120.640.66-0.18
0.80.79-0.860.120.80.460.170.77-0.070.80.430.990.00.070.430.440.590.470.80.70.780.190.670.67-0.2
0.410.56-0.10.810.46-0.080.840.34-0.750.52-0.07-0.010.00.87-0.070.70.610.210.310.60.340.270.120.57-0.71
0.450.560.040.840.49-0.180.980.4-0.890.63-0.080.060.070.87-0.080.760.710.540.350.650.370.240.230.66-0.9
0.440.41-0.430.070.380.36-0.090.390.090.281.00.430.43-0.07-0.080.190.040.120.510.250.5-0.020.680.250.07
0.860.82-0.320.940.880.190.730.83-0.880.840.190.430.440.70.760.190.910.440.80.910.820.390.480.93-0.89
0.870.85-0.420.770.90.160.760.85-0.790.90.040.590.590.610.710.040.910.560.790.960.810.450.410.98-0.84
0.430.53-0.30.280.45-0.090.60.41-0.480.630.120.450.470.210.540.120.440.560.380.550.390.080.580.55-0.61
0.980.91-0.670.590.950.520.370.99-0.480.850.510.790.80.310.350.510.80.790.380.861.00.380.710.88-0.53
0.930.93-0.590.740.970.240.70.88-0.70.950.250.70.70.60.650.250.910.960.550.860.870.40.560.99-0.77
0.990.92-0.660.610.960.50.40.99-0.510.850.50.780.780.340.370.50.820.810.391.00.870.390.70.89-0.55
0.390.33-0.140.370.380.140.260.42-0.380.28-0.020.120.190.270.24-0.020.390.450.080.380.40.390.20.43-0.36
0.670.7-0.620.280.640.390.260.66-0.280.650.680.640.670.120.230.680.480.410.580.710.560.70.20.55-0.36
0.940.91-0.510.770.960.230.70.91-0.740.940.250.660.670.570.660.250.930.980.550.880.990.890.430.55-0.8
-0.61-0.620.03-0.9-0.650.06-0.87-0.60.98-0.710.07-0.18-0.2-0.71-0.90.07-0.89-0.84-0.61-0.53-0.77-0.55-0.36-0.36-0.8
Click cells to compare fundamentals

Sabra Healthcare Account Relationship Matchups

Sabra Healthcare fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.1B6.0B6.0B5.7B5.4B4.2B
Short Long Term Debt Total2.4B3.7B4.2B2.7B2.4B2.2B
Other Current Liab(1.2B)(1.2B)(1.8B)(197.0M)61.2M64.2M
Total Current Liabilities108.8M146.3M143.0M142.3M231.4M243.0M
Total Stockholder Equity3.5B3.4B3.4B3.1B2.8B2.1B
Net Debt2.4B2.3B2.3B2.7B2.4B1.9B
Retained Earnings(573.3M)(716.2M)(1.1B)(1.5B)(1.7B)(1.6B)
Accounts Payable108.8M146.3M143.0M142.3M73.8M76.6M
Cash39.1M59.1M112.0M49.3M41.3M39.2M
Non Current Assets Total5.8B5.7B5.3B5.1B30.9M29.4M
Non Currrent Assets Other5.3B5.3B5.2B5.0B(194.7M)(185.0M)
Other Assets19M5.7B5.3B398.9M5.1B5.4B
Long Term Debt113.1M2.4B2.4B2.3B2.3B2.4B
Cash And Short Term Investments39.1M59.1M112.0M49.3M41.3M39.2M
Common Stock Total Equity2.1M2.1M2.3M2.3M2.7M2.8M
Common Stock Shares Outstanding188.1M207.3M219.1M230.9M232.8M131.1M
Liabilities And Stockholders Equity6.1B6.0B6.0B5.7B5.4B4.2B
Non Current Liabilities Total2.5B2.4B2.4B2.5B2.4B1.9B
Other Stockholder Equity4.6B4.9B5.6B4.5B4.5B2.9B
Total Liab2.6B2.6B2.6B2.7B2.6B2.0B
Total Current Assets307.0M329.0M653.1M613.2M212.7M387.9M
Accumulated Other Comprehensive Income(12.4M)(39.9M)(10.0M)19.1M23.7M24.9M
Common Stock2.1M2.1M2.3M2.3M2.3M1.4M
Good Will167.1M131.1M101.5M82.8M95.2M53.1M
Retained Earnings Total Equity(573.3M)(716.2M)(1.1B)(1.5B)(1.3B)(1.2B)
Other Current Assets(49.1M)(65.5M)(115.9M)(411.4M)68.1M71.5M
Intangible Assets101.5M82.8M54.1M40.1M30.9M59.5M
Property Plant Equipment5.3B5.3B5.2B5.0B5.7B3.7B
Net Tangible Assets3.5B3.4B3.3B3.0B3.5B2.4B
Net Receivables257.8M263.5M537.2M147.9M103.3M98.1M
Long Term Debt Total113.1M2.4B2.4B2.3B2.7B2.8B
Capital Surpluse4.1B4.2B4.5B4.5B5.2B2.9B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.111
Dividend Share
1.2
Earnings Share
0.41
Revenue Per Share
2.943
Quarterly Revenue Growth
0.107
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.